This website uses cookies to provide you with the best experience. By using this site you agree to our use of cookies. Please read our cookie notice for more information.

Investor Releases

Date Title View
19 February, 2013 ICON Reports Fourth Quarter 2012 Revenue of $300 Million, up 24% year on year, EPS of 34c and Full Year revenue of $1.12 billion, EPS of $1.00.
05 February, 2013 ICON Announces the Commencement of Direct Trading on NASDAQ
04 February, 2013 ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc.
21 December, 2012 Mr. Thomas Lynch Elected as Chairman of ICON plc
18 December, 2012 ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting relating to the proposed conversion to a direct listing of ICON's shares on NASDAQ
03 December, 2012 ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York
29 November, 2012 Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board
16 November, 2012 ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ
01 November, 2012 ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)
05 September, 2012 ICON Forms Strategic Partnership with University College Dublin
24 July, 2012 ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
20 July, 2012 ICON Shareholders Vote in Favour of All Resolutions at Its Annual General Meeting
12 June, 2012 ICON Announces Peter Gray to Retire from ICON Board of Directors
24 April, 2012 ICON reports a 10% increase in first quarter 2012 revenue to $252m, up 10% year on year, EPS of 15 cents, net new business awards of $385 million and a B:B of 1.5. (NASDAQ:ICLR) (ISIN:IE0005711209)
05 March, 2012 ICON Selected by Roche for Technology Partnership
28 February, 2012 ICON Acquires PriceSpective
16 February, 2012 ICON reports fourth quarter 2011 revenue of $243m, up 5% year on year, and EPS of $0.07. Backlog increases 19%. (NASDAQ:ICLR) (ISIN:IE0005711209)
15 February, 2012 ICON Completes Acquisition of BeijingWits Medical Consulting Ltd
09 January, 2012 ICON Selected by Shire plc's Specialty Pharmaceuticals division as Global Strategic Partner for Clinical Research and Central Laboratory Services
27 December, 2011 ICON Announces Dr. Anthony Murphy To Retire From Board of Directors
Displaying 121 - 140 of 300

Search Investor